If you've heard of the "Blue Zones" — the small handful of places in the world where people routinely live past 100 — you've probably heard of Okinawa, Japan.
What gets discussed less often is the part that should change how we think about blood sugar entirely:
Traditional Okinawans, on their ancestral diet, had virtually no type 2 diabetes. Not low rates. Almost none. They also had remarkably low rates of heart disease and metabolic syndrome — even into their nineties.
For decades, researchers attributed this to genetics or to the general "healthy lifestyle" of the region. But more recent research has pointed at something more specific: a marine compound called astaxanthin, found in high concentrations in the wild salmon, shrimp, and algae that made up a large part of the traditional Okinawan diet.
Astaxanthin is interesting for one specific reason. Of every known antioxidant, it is essentially the only one that can position itself across both the inner and outer layer of a cell membrane simultaneously.
It's the one antioxidant that doesn't have the "half coverage" problem from Reason #3. It sits inside the membrane like a structural beam — protecting the insulin receptor from oxidative damage on both sides at once.
12 wk
In a 2021 clinical trial published in Diabetes, Obesity and Metabolism, 12mg of astaxanthin daily significantly reduced HbA1c in participants with prediabetes — with zero clinically apparent side effects reported.
That's the part that should stop you. Zero clinically apparent side effects. No diarrhea. No nausea. No exhaustion. No injection sites. Just the cellular repair mechanism, working at the right layer, over twelve weeks.
This isn't ancient wisdom dressed up in a lab coat. It's a published clinical study using a specific, measurable dose — and the dose is the part most people get wrong, which brings us to the final reason.